Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Recruiting
N/A
Interventional Study
Thyroid Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Aarhus University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age\>18 years and able to give informed consent.
* Suspicion or diagnosis of thyroid cancer.
* Planned total thyroidectomy or completion thyroidectomy.
* Normocalcemia prior to surgery.
Exclusion Criteria:
* Planned simultaneous parathyroid surgery.
* Treatment with active v…
Contacts